New Delhi, Dec 31 (IANS) As circumstances of the brand new Omicron sub-variant JN.1 proceed to rise globally, together with in India, there’s a worry amongst many a couple of potential Covid wave early subsequent yr that will derail normalcy as soon as once more. Are these fears actual?India recorded 743 recent circumstances of Covid-19 within the final 24 hours (as of Saturday). The complete lively caseload elevated by seven, reaching 3,997, in accordance with the Union Health Ministry.

A complete of 162 JN.1 circumstances have been reported in India up to now, with Kerala reporting the very best quantity at 83.

With this, the entire depend of coronavirus circumstances in India since its outbreak in January 2020 has reached 4,50,12,484. The demise toll on account of COVID-19 circumstances in India has risen to five,33,358, reflecting seven deaths within the final 24 hours.

Globally, circumstances of JN.1 have been reported from the US, some European nations, Singapore and China.

Maria Van Kerkhove, COVID-19 Technical Lead at WHO, mentioned on Saturday that from a restricted variety of nations reporting, there was a 35 per cent improve in Covid-19 hospitalisations and ICU admissions within the final month.

“SARS-CoV-2, influenza and other respiratory pathogens continue to be on the rise. Take measures to protect yourself from infection,” she suggested.

Kerkhove mentioned that JN.1 continues to rise in detection, however what issues is that Covid-19 is circulating in all nations.

“You can protect yourself from infection and severe disease. Mask, ventilate, test, treat, vaccinate: boost every 6-12 months depending on your risk group,” she posted on X.

According to Dr Soumya Swaminathan, former DG, Indian Council of Medical Research (ICMR) the JN.1 Covid-19 variant is extra transmissible and infectious as in comparison with different variants.

However, “the public health risk is still low because we all have immunity now because of the vaccines and the natural infections we’ve had in the past,” she mentioned.

The World Health Organisation (WHO) has categorised JN.1 as a separate “variant of interest” given its quickly rising unfold however mentioned it poses a “low” international public well being danger.

According to Dr Ishwar Gilada, Consultant in Infectious Diseases Unison Medicare and Research Centre, Mumbai, until JN.1 turns into ‘variant of concern’ (VoC), it mustn’t trouble the frequent man.

“India had managed the Covid-19 pandemic much better than many powerful countries. India had one of the best vaccination against Covid-19, with 75 per cent of the population fully vaccinated and 35 per cent population having received booster (third dose),” he informed IANS.

The third wave orchestrated by the Omicron Variant primarily with the BA.2 sub-variant contaminated the vast majority of the inhabitants with least morbidity and mortality.

“In fact BA.2 was a saviour for India, from infections with BA.4 and BA.5 as well as descendants of BA.2 like BA.2.86 (Pirola). We are much better prepared now than ever before. Not only that, India supports more than 50 countries in Africa and elsewhere with preparedness, medicines and vaccines,” he added.

Though identified in August 2023 in Luxembourg and currently present in more than 40 countries, JN.1 has neither caused larger morbidity or any remarkable mortality.

“Deaths are only in co-morbid people globally. There is neither clustering of infections with JN.1 nor it is yet a dominant strain of coronavirus in India. The presence of JN.1 has not increased demand for oxygen, beds, ICU beds or ventilators,” said Dr Gilada.

Experts request masking for senior citizens and those with severe comorbidities, as well as those going to crowded places.

“Individuals with sure comorbidities face an elevated danger of extreme outcomes and elevated mortality from Covid,” Dr. Vikas Chopra, Sr. Consultant Interventional Cardiologist, Primus Super Specialty Hospital, told IANS.

“Common comorbidities related to larger demise danger embrace cardiovascular illnesses like hypertension and coronary artery illness, power respiratory situations resembling power obstructive pulmonary illness (COPD), diabetes, weight problems, and compromised immune programs,” Dr. Chopra mentioned.

–IANS

na/bg